Business · 1 sources covering this

Biocon Q1 Results: Profit Spikes 350%, Revenue Exceeds Rs 4,300 Crore

Biocon Q1 profit surged 348% to Rs. 141 crore as revenue rose 10% to Rs. 4,336 crore. Biosimilars and generics led growth, while EBITDA margin remained stable.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·1h ago
Biocon Q1 Results: Profit Spikes 350%, Revenue Exceeds Rs 4,300 Crore
Biocon Q1 profit surged 348% to Rs. 141 crore as revenue rose 10% to Rs. 4,336 crore. Biosimilars and generics led growth, while EBITDA margin remained stable.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/e774e8f1a1ece7365f1cfc796071ffc930a17aae"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Biocon Q1 Results: Profit Spikes 350%, Revenue Exceeds Rs 4,300 Crore"></iframe>

Biocon Q1 Results: Profit Spikes 350%, Revenue Exceeds Rs 4,300 Crore

How 1 sources are covering this

Biocon Q1 Results: Profit Spikes 350%, Revenue Exceeds Rs 4,300 Crore

More from Business

RBI plans to roll out polymer banknotes by FY28

Spider-Man: Brand New Day Box Office Collection Day 7: MCU Film Continues Impressive Run In India

RBI to resume licensing of Urban Cooperative Banks

Don't Blame CAS: Nithin Kamath Flags High STT, Limited Shorting For Recent Closing Swings

Reader

Trust & legal

Across the network